{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T22:51:54Z","timestamp":1771455114615,"version":"3.50.1"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2016,2,19]],"date-time":"2016-02-19T00:00:00Z","timestamp":1455840000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Differ"],"published-print":{"date-parts":[[2016,7]]},"DOI":"10.1038\/cdd.2015.165","type":"journal-article","created":{"date-parts":[[2016,2,19]],"date-time":"2016-02-19T13:01:17Z","timestamp":1455886877000},"page":"1152-1164","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":51,"title":["Molecular profiling reveals primary mesothelioma cell lines recapitulate human disease"],"prefix":"10.1038","volume":"23","author":[{"given":"T","family":"Chernova","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"X M","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I R","family":"Powley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S","family":"Galavotti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S","family":"Grosso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F A","family":"Murphy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G J","family":"Miles","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L","family":"Cresswell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A V","family":"Antonov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J","family":"Bennett","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A","family":"Nakas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D","family":"Dinsdale","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K","family":"Cain","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Bushell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A E","family":"Willis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"MacFarlane","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,2,19]]},"reference":[{"key":"BFcdd2015165_CR1","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1002\/jcp.22724","volume":"227","author":"M Carbone","year":"2012","unstructured":"Carbone M, Ly BH, Dodson RF, Pagano I, Morris PT, Dogan UA et al. Malignant mesothelioma: facts, myths, and hypotheses. J Cell Physiol 2012; 227: 44\u201358.","journal-title":"J Cell Physiol"},{"key":"BFcdd2015165_CR2","doi-asserted-by":"publisher","first-page":"82","DOI":"10.4103\/0019-5278.146897","volume":"18","author":"C Bianchi","year":"2014","unstructured":"Bianchi C, Bianchi T . Global mesothelioma epidemic: trend and features. Indian J Occup Environ Med 2014; 18: 82\u201388.","journal-title":"Indian J Occup Environ Med"},{"key":"BFcdd2015165_CR3","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1097\/CEJ.0b013e32832f9bee","volume":"18","author":"M Goldberg","year":"2009","unstructured":"Goldberg M, Luce D . The health impact of nonoccupational exposure to asbestos: what do we know? Eur J Cancer Prev 2009; 18: 489\u2013503.","journal-title":"Eur J Cancer Prev"},{"key":"BFcdd2015165_CR4","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1378\/chest.109.1.109","volume":"109","author":"L Johansson","year":"1996","unstructured":"Johansson L, Linden CJ . Aspects of histopathologic subtype as a prognostic factor in 85 pleural mesotheliomas. Chest 1996; 109: 109\u2013114.","journal-title":"Chest"},{"key":"BFcdd2015165_CR5","doi-asserted-by":"publisher","first-page":"2636","DOI":"10.1200\/JCO.2003.11.136","volume":"21","author":"NJ Vogelzang","year":"2003","unstructured":"Vogelzang NJ, Rusthoven JJ, Symanowski J, Denham C, Kaukel E, Ruffie P et al. Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma. J Clin Oncol 2003; 21: 2636\u20132644.","journal-title":"J Clin Oncol"},{"key":"BFcdd2015165_CR6","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1002\/jcb.240630509","volume":"24","author":"HI Pass","year":"1996","unstructured":"Pass HI, Mew DJ . In vitro and in vivo studies of mesothelioma. J Cell Biochem Suppl 1996; 24: 142\u2013151.","journal-title":"J Cell Biochem Suppl"},{"key":"BFcdd2015165_CR7","doi-asserted-by":"publisher","first-page":"e58132","DOI":"10.1371\/journal.pone.0058132","volume":"8","author":"V Relan","year":"2013","unstructured":"Relan V, Morrison L, Parsonson K, Clarke BE, Duhig EE, Windsor MN et al. Phenotypes and karyotypes of human malignant mesothelioma cell lines. PloS One 2013; 8: e58132.","journal-title":"PloS One"},{"key":"BFcdd2015165_CR8","first-page":"197","volume":"28","author":"M Kobayashi","year":"2008","unstructured":"Kobayashi M, Takeuchi T, Ohtsuki Y . Establishment of three novel human malignant pleural mesothelioma cell lines: morphological and cytogenetical studies and EGFR mutation status. Anticancer Res 2008; 28: 197\u2013208.","journal-title":"Anticancer Res"},{"key":"BFcdd2015165_CR9","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.cancergencyto.2007.03.005","volume":"176","author":"HJ Schulten","year":"2007","unstructured":"Schulten HJ, Perske C, Thelen P, Polten A, Borst C, Gunawan B et al. Establishment and characterization of two distinct malignant mesothelioma cell lines with common clonal origin. Cancer Genet Cytogenet 2007; 176: 35\u201347.","journal-title":"Cancer Genet Cytogenet"},{"key":"BFcdd2015165_CR10","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1111\/j.1349-7006.2006.00184.x","volume":"97","author":"N Usami","year":"2006","unstructured":"Usami N, Fukui T, Kondo M, Taniguchi T, Yokoyama T, Mori S et al. Establishment and characterization of four malignant pleural mesothelioma cell lines from Japanese patients. Cancer Sci 2006; 97: 387\u2013394.","journal-title":"Cancer Sci"},{"key":"BFcdd2015165_CR11","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1186\/1471-2407-6-130","volume":"6","author":"D Martarelli","year":"2006","unstructured":"Martarelli D, Catalano A, Procopio A, Orecchia S, Libener R, Santoni G . Characterization of human malignant mesothelioma cell lines orthotopically implanted in the pleural cavity of immunodeficient mice for their ability to grow and form metastasis. BMC Cancer 2006; 6: 130.","journal-title":"BMC Cancer"},{"key":"BFcdd2015165_CR12","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1038\/nbt.3080","volume":"33","author":"C Klijn","year":"2015","unstructured":"Klijn C, Durinck S, Stawiski EW, Haverty PM, Jiang Z, Liu H et al. A comprehensive transcriptional portrait of human cancer cell lines. Nat Biotechnol 2015; 33: 306\u2013312.","journal-title":"Nat Biotechnol"},{"key":"BFcdd2015165_CR13","doi-asserted-by":"publisher","first-page":"175","DOI":"10.2486\/indhealth.40.175","volume":"40","author":"F Kitamura","year":"2002","unstructured":"Kitamura F, Araki S, Suzuki Y, Yokoyama K, Tanigawa T, Iwasaki R . Assessment of the mutations of p53 suppressor gene and Ha- and Ki-ras oncogenes in malignant mesothelioma in relation to asbestos exposure: a study of 12 American patients. Ind Health 2002; 40: 175\u2013181.","journal-title":"Ind Health"},{"key":"BFcdd2015165_CR14","first-page":"1227","volume":"55","author":"Y Sekido","year":"1995","unstructured":"Sekido Y, Pass HI, Bader S, Mew DJ, Christman MF, Gazdar AF et al. Neurofibromatosis type 2 (NF2) gene is somatically mutated in mesothelioma but not in lung cancer. Cancer Res 1995; 55: 1227\u20131231.","journal-title":"Cancer Res"},{"key":"BFcdd2015165_CR15","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1093\/carcin\/23.7.1127","volume":"23","author":"T Hirao","year":"2002","unstructured":"Hirao T, Bueno R, Chen CJ, Gordon GJ, Heilig E, Kelsey KT . Alterations of the p16(INK4) locus in human malignant mesothelial tumors. Carcinogenesis 2002; 23: 1127\u20131130.","journal-title":"Carcinogenesis"},{"key":"BFcdd2015165_CR16","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1158\/0008-5472.CAN-14-1008","volume":"75","author":"G Guo","year":"2015","unstructured":"Guo G, Chmielecki J, Goparaju C, Heguy A, Dolgalev I, Carbone M et al. Whole-exome sequencing reveals frequent genetic Alterations in BAP1, NF2, CDKN2A, and CUL1 in Malignant Pleural Mesothelioma. Cancer Res 2015; 75: 264\u2013269.","journal-title":"Cancer Res"},{"key":"BFcdd2015165_CR17","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1083\/jcb.74.1.98","volume":"74","author":"M Simionescu","year":"1977","unstructured":"Simionescu M, Simionescu N . Organization of cell junctions in the peritoneal mesothelium. J Cell Biol 1977; 74: 98\u2013110.","journal-title":"J Cell Biol"},{"key":"BFcdd2015165_CR18","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.lungcan.2009.01.011","volume":"66","author":"Y Takeshima","year":"2009","unstructured":"Takeshima Y, Inai K, Amatya VJ, Gemba K, Aoe K, Fujimoto N et al. Accuracy of pathological diagnosis of mesothelioma cases in Japan: clinicopathological analysis of 382 cases. Lung Cancer 2009; 66: 191\u2013197.","journal-title":"Lung Cancer"},{"key":"BFcdd2015165_CR19","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/1746-1596-5-47","volume":"5","author":"HP Sandeck","year":"2010","unstructured":"Sandeck HP, Roe OD, Kjaerheim K, Willen H, Larsson E . Re-evaluation of histological diagnoses of malignant mesothelioma by immunohistochemistry. Diagn Pathol 2010; 5: 47.","journal-title":"Diagn Pathol"},{"key":"BFcdd2015165_CR20","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1038\/modpathol.3800534","volume":"19","author":"H Yaziji","year":"2006","unstructured":"Yaziji H, Battifora H, Barry TS, Hwang HC, Bacchi CE, McIntosh MW et al. Evaluation of 12 antibodies for distinguishing epithelioid mesothelioma from adenocarcinoma: identification of a three-antibody immunohistochemical panel with maximal sensitivity and specificity. Mod Pathol 2006; 19: 514\u2013523.","journal-title":"Mod Pathol"},{"key":"BFcdd2015165_CR21","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.lungcan.2008.08.014","volume":"64","author":"C Thurneysen","year":"2009","unstructured":"Thurneysen C, Opitz I, Kurtz S, Weder W, Stahel RA, Felley-Bosco E . Functional inactivation of NF2\/merlin in human mesothelioma. Lung Cancer 2009; 64: 140\u2013147.","journal-title":"Lung Cancer"},{"key":"BFcdd2015165_CR22","doi-asserted-by":"publisher","first-page":"4235","DOI":"10.1128\/MCB.01578-08","volume":"29","author":"MA Lopez-Lago","year":"2009","unstructured":"Lopez-Lago MA, Okada T, Murillo MM, Socci N, Giancotti FG . Loss of the tumor suppressor gene NF2, encoding merlin, constitutively activates integrin-dependent mTORC1 signaling. Mol Cell Biol 2009; 29: 4235\u20134249.","journal-title":"Mol Cell Biol"},{"key":"BFcdd2015165_CR23","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1038\/modpathol.3800544","volume":"19","author":"NG Ordonez","year":"2006","unstructured":"Ordonez NG . The diagnostic utility of immunohistochemistry in distinguishing between epithelioid mesotheliomas and squamous carcinomas of the lung: a comparative study. Mod Pathol 2006; 19: 417\u2013428.","journal-title":"Mod Pathol"},{"key":"BFcdd2015165_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/sj.bjc.6603518","volume":"96","author":"A Wicki","year":"2007","unstructured":"Wicki A, Christofori G . The potential role of podoplanin in tumour invasion. Br J Cancer 2007; 96: 1\u20135.","journal-title":"Br J Cancer"},{"key":"BFcdd2015165_CR25","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1186\/1476-4598-12-168","volume":"12","author":"K Shindo","year":"2013","unstructured":"Shindo K, Aishima S, Ohuchida K, Fujiwara K, Fujino M, Mizuuchi Y et al. Podoplanin expression in cancer-associated fibroblasts enhances tumor progression of invasive ductal carcinoma of the pancreas. Mol Cancer 2013; 12: 168.","journal-title":"Mol Cancer"},{"key":"BFcdd2015165_CR26","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1016\/j.biocel.2011.02.010","volume":"43","author":"B Fernandez-Munoz","year":"2011","unstructured":"Fernandez-Munoz B, Yurrita MM, Martin-Villar E, Carrasco-Ramirez P, Megias D, Renart J et al. The transmembrane domain of podoplanin is required for its association with lipid rafts and the induction of epithelial-mesenchymal transition. Int J Biochem Cell Biol 2011; 43: 886\u2013896.","journal-title":"Int J Biochem Cell Biol"},{"key":"BFcdd2015165_CR27","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1158\/1078-0432.CCR-13-2429","volume":"20","author":"A de Reynies","year":"2014","unstructured":"de Reynies A, Jaurand MC, Renier A, Couchy G, Hysi I, Elarouci N et al. Molecular classification of malignant pleural mesothelioma: identification of a poor prognosis subgroup linked to the epithelial-to-mesenchymal transition. Clin Cancer Res 2014; 20: 1323\u20131334.","journal-title":"Clin Cancer Res"},{"key":"BFcdd2015165_CR28","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1038\/nm0795-686","volume":"1","author":"A Merlo","year":"1995","unstructured":"Merlo A, Herman JG, Mao L, Lee DJ, Gabrielson E, Burger PC et al. 5' CpG island methylation is associated with transcriptional silencing of the tumour suppressor p16\/CDKN2\/MTS1 in human cancers. Nat Med 1995; 1: 686\u2013692.","journal-title":"Nat Med"},{"key":"BFcdd2015165_CR29","doi-asserted-by":"publisher","first-page":"1858","DOI":"10.1038\/leu.2009.114","volume":"23","author":"C O'Riain","year":"2009","unstructured":"O'Riain C, O'Shea DM, Yang Y, Le Dieu R, Gribben JG, Summers K et al. Array-based DNA methylation profiling in follicular lymphoma. Leukemia 2009; 23: 1858\u20131866.","journal-title":"Leukemia"},{"key":"BFcdd2015165_CR30","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/j.lungcan.2013.05.014","volume":"81","author":"F Vandermeers","year":"2013","unstructured":"Vandermeers F, Neelature Sriramareddy S, Costa C, Hubaux R, Cosse JP, Willems L . The role of epigenetics in malignant pleural mesothelioma. Lung Cancer 2013; 81: 311\u2013318.","journal-title":"Lung Cancer"},{"key":"BFcdd2015165_CR31","doi-asserted-by":"publisher","first-page":"4980","DOI":"10.1073\/pnas.1102198108","volume":"108","author":"C Yang","year":"2011","unstructured":"Yang C, Asthagiri AR, Iyer RR, Lu J, Xu DS, Ksendzovsky A et al. Missense mutations in the NF2 gene result in the quantitative loss of merlin protein and minimally affect protein intrinsic function. Proc Natl Acad Sci USA 2011; 108: 4980\u20134985.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFcdd2015165_CR32","doi-asserted-by":"publisher","first-page":"3799","DOI":"10.1038\/sj.onc.1206593","volume":"22","author":"J Fleury-Feith","year":"2003","unstructured":"Fleury-Feith J, Lecomte C, Renier A, Matrat M, Kheuang L, Abramowski V et al. Hemizygosity of Nf2 is associated with increased susceptibility to asbestos-induced peritoneal tumours. Oncogene 2003; 22: 3799\u20133805.","journal-title":"Oncogene"},{"key":"BFcdd2015165_CR33","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1038\/ncb1641","volume":"9","author":"X Tang","year":"2007","unstructured":"Tang X, Jang SW, Wang X, Liu Z, Bahr SM, Sun SY et al. Akt phosphorylation regulates the tumour-suppressor merlin through ubiquitination and degradation. Nat Cell Biol 2007; 9: 1199\u20131207.","journal-title":"Nat Cell Biol"},{"key":"BFcdd2015165_CR34","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1038\/nature10983","volume":"486","author":"C Curtis","year":"2012","unstructured":"Curtis C, Shah SP, Chin SF, Turashvili G, Rueda OM, Dunning MJ et al. The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups. Nature 2012; 486: 346\u2013352.","journal-title":"Nature"},{"key":"BFcdd2015165_CR35","doi-asserted-by":"publisher","first-page":"939","DOI":"10.4161\/cbt.12.11.18140","volume":"12","author":"S Romero-Garcia","year":"2011","unstructured":"Romero-Garcia S, Lopez-Gonzalez JS, Baez-Viveros JL, Aguilar-Cazares D, Prado-Garcia H . Tumor cell metabolism: an integral view. Cancer Biol Ther 2011; 12: 939\u2013948.","journal-title":"Cancer Biol Ther"},{"key":"BFcdd2015165_CR36","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1007\/s12307-012-0099-6","volume":"5","author":"D Tarin","year":"2012","unstructured":"Tarin D . Clinical and biological implications of the tumor microenvironment. Cancer Microenviron 2012; 5: 95\u2013112.","journal-title":"Cancer Microenviron"},{"key":"BFcdd2015165_CR37","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1016\/j.redox.2013.12.028","volume":"2","author":"W Dott","year":"2014","unstructured":"Dott W, Mistry P, Wright J, Cain K, Herbert KE . Modulation of mitochondrial bioenergetics in a skeletal muscle cell line model of mitochondrial toxicity. Redox Biol 2014; 2: 224\u2013233.","journal-title":"Redox Biol"},{"key":"BFcdd2015165_CR38","doi-asserted-by":"publisher","first-page":"4996","DOI":"10.1038\/onc.2012.13","volume":"31","author":"GL Robinson","year":"2012","unstructured":"Robinson GL, Dinsdale D, MacFarlane M, Cain K . Switching from aerobic glycolysis to oxidative phosphorylation modulates the sensitivity of mantle cell lymphoma cells to TRAIL. Oncogene 2012; 31: 4996\u20135006.","journal-title":"Oncogene"},{"key":"BFcdd2015165_CR39","doi-asserted-by":"publisher","first-page":"R287","DOI":"10.1677\/ERC-10-0106","volume":"17","author":"JF Barger","year":"2010","unstructured":"Barger JF, Plas DR . Balancing biosynthesis and bioenergetics: metabolic programs in oncogenesis. Endocr Relat Cancer 2010; 17: R287\u2013R304.","journal-title":"Endocr Relat Cancer"},{"key":"BFcdd2015165_CR40","doi-asserted-by":"publisher","first-page":"42","DOI":"10.6004\/jnccn.2012.0007","volume":"10","author":"MG Zauderer","year":"2012","unstructured":"Zauderer MG, Krug LM . Novel therapies in phase II and III trials for malignant pleural mesothelioma. J Natl Compr Cancer Netw 2012; 10: 42\u201347.","journal-title":"J Natl Compr Cancer Netw"},{"key":"BFcdd2015165_CR41","first-page":"508","volume":"1","author":"AK Nowak","year":"2012","unstructured":"Nowak AK . Chemotherapy for malignant pleural mesothelioma: a review of current management and a look to the future. Ann Cardiothorac Surg 2012; 1: 508\u2013515.","journal-title":"Ann Cardiothorac Surg"},{"key":"BFcdd2015165_CR42","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.cell.2006.10.003","volume":"127","author":"WY Kim","year":"2006","unstructured":"Kim WY, Sharpless NE . The regulation of INK4\/ARF in cancer and aging. Cell 2006; 127: 265\u2013275.","journal-title":"Cell"},{"key":"BFcdd2015165_CR43","doi-asserted-by":"publisher","first-page":"5566","DOI":"10.1021\/bi200642e","volume":"50","author":"J Li","year":"2011","unstructured":"Li J, Poi MJ, Tsai MD . Regulatory mechanisms of tumor suppressor P16(INK4A) and their relevance to cancer. Biochemistry 2011; 50: 5566\u20135582.","journal-title":"Biochemistry"},{"key":"BFcdd2015165_CR44","first-page":"237ra268","volume":"6","author":"IM Shapiro","year":"2014","unstructured":"Shapiro IM, Kolev VN, Vidal CM, Kadariya Y, Ring JE, Wright Q et al. Merlin deficiency predicts FAK inhibitor sensitivity: a synthetic lethal relationship. Sci Transl Med 2014; 6: 237ra268.","journal-title":"Sci Transl Med"},{"key":"BFcdd2015165_CR45","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1158\/1078-0432.CCR-11-2259","volume":"18","author":"M Carbone","year":"2012","unstructured":"Carbone M, Yang H . Molecular pathways: targeting mechanisms of asbestos and erionite carcinogenesis in mesothelioma. Clin Cancer Res 2012; 18: 598\u2013604.","journal-title":"Clin Cancer Res"},{"key":"BFcdd2015165_CR46","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1111\/j.1440-1827.2011.02666.x","volume":"61","author":"Y Sekido","year":"2011","unstructured":"Sekido Y . Inactivation of Merlin in malignant mesothelioma cells and the Hippo signaling cascade dysregulation. Pathol Int 2011; 61: 331\u2013344.","journal-title":"Pathol Int"},{"key":"BFcdd2015165_CR47","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1038\/nature12437","volume":"501","author":"JR Dorr","year":"2013","unstructured":"Dorr JR, Yu Y, Milanovic M, Beuster G, Zasada C, Dabritz JH et al. Synthetic lethal metabolic targeting of cellular senescence in cancer therapy. Nature 2013; 501: 421\u2013425.","journal-title":"Nature"},{"key":"BFcdd2015165_CR48","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1096\/fj.04-3062fje","volume":"19","author":"W Parson","year":"2005","unstructured":"Parson W, Kirchebner R, Muhlmann R, Renner K, Kofler A, Schmidt S et al. Cancer cell line identification by short tandem repeat profiling: power and limitations. FASEB J 2005; 19: 434\u2013436.","journal-title":"FASEB J"},{"issue":"Web Server issu","key":"BFcdd2015165_CR49","doi-asserted-by":"publisher","first-page":"W78","DOI":"10.1093\/nar\/gkq482","volume":"38","author":"AV Antonov","year":"2010","unstructured":"Antonov AV, Schmidt EE, Dietmann S, Krestyaninova M, Hermjakob H . R spider: a network-based analysis of gene lists by combining signaling and metabolic pathways from Reactome and KEGG databases. Nucleic Acids Res 2010; 38 (Web Server issue): W78\u2013W83.","journal-title":"Nucleic Acids Res"},{"issue":"Web Server issu","key":"BFcdd2015165_CR50","doi-asserted-by":"publisher","first-page":"W323","DOI":"10.1093\/nar\/gkr372","volume":"39","author":"AV Antonov","year":"2011","unstructured":"Antonov AV . BioProfiling.de: analytical web portal for high-throughput cell biology. Nucleic Acids Res 2011; 39 (Web Server issue): W323\u2013W327.","journal-title":"Nucleic Acids Res"},{"key":"BFcdd2015165_CR51","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1016\/j.jmoldx.2013.04.008","volume":"15","author":"DA Moore","year":"2013","unstructured":"Moore DA, Saldanha G, Ehdode A, Potter L, Dyall L, Bury D et al. Accurate detection of copy number changes in DNA extracted from formalin-fixed, paraffin-embedded melanoma tissue using duplex ratio tests. J Mol Diagn 2013; 15: 687\u2013694.","journal-title":"J Mol Diagn"}],"container-title":["Cell Death & Differentiation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/cdd2015165.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/cdd2015165","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/cdd2015165.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T13:09:00Z","timestamp":1684415340000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/cdd2015165"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,2,19]]},"references-count":51,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2016,7]]}},"alternative-id":["BFcdd2015165"],"URL":"https:\/\/doi.org\/10.1038\/cdd.2015.165","relation":{},"ISSN":["1350-9047","1476-5403"],"issn-type":[{"value":"1350-9047","type":"print"},{"value":"1476-5403","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,2,19]]},"assertion":[{"value":"28 May 2015","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 November 2015","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 November 2015","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 February 2016","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}